The clinical severity of hemoglobin S/Black (Aγδβ)0‐thalassemia
- 28 April 2017
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (11)
Abstract
Hemoglobin S/Black (Aγδβ)0‐thalassemia is a rare sickle cell disease (SCD) variant. On the basis of limited descriptions in the literature, the disease is reported as a mild microcytic anemia with an uncomplicated course. We report the clinical and laboratory data of nine patients whose diagnoses were confirmed by DNA‐based techniques. Despite having mild anemia and high fetal hemoglobin level postinfancy, these patients developed many of the classic complications of SCD, including vaso‐occlusive crisis, acute chest syndrome, avascular necrosis, and cholelithiasis. On the basis of these findings, we recommend that patients with this rare disorder receive specialized hematology care according to SCD guidelines.Keywords
Funding Information
- National Cancer Institute (P30 CA008748)
This publication has 6 references indexed in Scilit:
- Fetal hemoglobin in sickle cell anemia: a glass half full?Blood, 2014
- Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobinBritish Journal of Haematology, 2011
- Clinical and Molecular Characterization of βSandGγ(Aγδβ)0-Thalassemia in Eastern IndiaHemoglobin, 2010
- Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studiesNucleic Acids Research, 2004
- Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell diseaseAmerican Journal of Hematology, 1997
- (Aγδβ)°‐Thalassaemia in Blacks is due to a deletion of 34 kbp of DNABritish Journal of Haematology, 1985